TELA Bio, Inc. (TELA) stock
TELANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$0.76+0.00 (+0.07%)
Close on Nov 17, 2026Market cap $34.21MP/E –Yield –
TELA Bio profit margin
Profit margin (net margin) is net income as a percentage of revenue.
TELA Bio's profit margin for the twelve months ending Jun 30, 2026 was -51.5%. For fiscal 2025 it was -48.4%, against -54.6% the year before. The highest annual figure on record is -48.4% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -48.4% | +6.2 |
| FY2024 | Dec 31, 2024 | -54.6% | +25.2 |
| FY2023 | Dec 31, 2023 | -79.8% | +27.1 |
| FY2022 | Dec 31, 2022 | -106.9% | +6.0 |
| FY2021 | Dec 31, 2021 | -112.9% | +45.2 |
| FY2020 | Dec 31, 2020 | -158.1% | −12.9 |
| FY2019 | Dec 31, 2019 | -145.2% | +109.7 |
| FY2018 | Dec 31, 2018 | -254.9% | +247.6 |
| FY2017 | Dec 31, 2017 | -502.6% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -58.4% | −9.2 |
| Q1 FY2026 | Mar 31, 2026 | -64.4% | −3.6 |
| Q4 FY2025 | Dec 31, 2025 | -43.3% | +8.9 |
| Q3 FY2025 | Sep 30, 2025 | -41.6% | +13.1 |
| Q2 FY2025 | Jun 30, 2025 | -49.1% | +29.2 |
| Q1 FY2025 | Mar 31, 2025 | -60.8% | −26.7 |
| Q4 FY2024 | Dec 31, 2024 | -52.2% | +23.7 |
| Q3 FY2024 | Sep 30, 2024 | -54.7% | +18.1 |
| Q2 FY2024 | Jun 30, 2024 | -78.3% | −3.9 |
| Q1 FY2024 | Mar 31, 2024 | -34.1% | +66.9 |
| Q4 FY2023 | Dec 31, 2023 | -75.8% | +10.0 |
| Q3 FY2023 | Sep 30, 2023 | -72.8% | +23.2 |
| Q2 FY2023 | Jun 30, 2023 | -74.4% | +48.0 |
| Q1 FY2023 | Mar 31, 2023 | -101.0% | +31.0 |
| Q4 FY2022 | Dec 31, 2022 | -85.9% | +17.1 |
| Q3 FY2022 | Sep 30, 2022 | -96.0% | +12.0 |
| Q2 FY2022 | Jun 30, 2022 | -122.4% | −13.2 |
| Q1 FY2022 | Mar 31, 2022 | -132.0% | +6.5 |
| Q4 FY2021 | Dec 31, 2021 | -102.9% | +34.5 |
| Q3 FY2021 | Sep 30, 2021 | -108.0% | +37.0 |
| Q2 FY2021 | Jun 30, 2021 | -109.2% | +64.2 |
| Q1 FY2021 | Mar 31, 2021 | -138.4% | +55.3 |
| Q4 FY2020 | Dec 31, 2020 | -137.5% | +21.8 |
| Q3 FY2020 | Sep 30, 2020 | -145.0% | +35.5 |
| Q2 FY2020 | Jun 30, 2020 | -173.4% | +131.1 |
| Q1 FY2020 | Mar 31, 2020 | -193.8% | −66.9 |
| Q2 FY2019 | Jun 30, 2019 | -159.3% | – |
| Q1 FY2019 | Mar 31, 2019 | -180.5% | – |
| Q4 FY2018 | Dec 31, 2018 | -304.5% | – |
| Q3 FY2018 | Sep 30, 2018 | -126.9% | – |
See a number that looks wrong?